[Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
D001285:Atropine; D001592:Benzyl Alcohols; D001659:Biliary Tract; D001660:Biliary Tract Diseases; D002756:Cholagogues and Choleretics / Q000628:therapy*; D005767:Gastrointestinal Diseases; D006801:Humans; D008107:Liver Diseases / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010208:Papaverine; D010276:Parasympatholytics
D001592:Benzyl Alcohols; D002756:Cholagogues and Choleretics; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D001285:Atropine; D010208:Papaverine; C013992:fenipentol
BILIARY TRACT/diseases; CHOLAGOGUES AND CHOLERETICS/therapy; LIVER DISEASES/therapy; MUSCLE RELAXANTS/therapy